234 Results

People

  1. Perales
    Perales
  2. Giralt
    Giralt
  3. Devlin
    Devlin
  4. Nelson
    Nelson
  5. Jones
    Jones
  6. Lacouture
    Lacouture
  7. Disa
    Disa
  8. Palomba
    Palomba
  9. Shah
    Shah
  10. Shouval
    Shouval

Groups

  1. Department of Medicine (116)
  2. Survivorship Research (64)
  3. Hematologic Malignancies, Division of (59)
  4. Surgery (59)
  5. Center for Hematologic Malignancies (51)
  6. Solid Tumor Oncology Division (45)
  7. Division of Subspecialty Medicine (38)
  8. Sloan Kettering Institute Postdocs (37)
  9. Epidemiology and Biostatistics (33)
  10. Bone Marrow Transplant (31)
  1. "adverse event"
Formats
  1. Journal Article (160)
  2. Review (40)
  3. Editorial (10)
  4. Research Letter (8)
  5. Correspondence (6)
  6. Guidelines (5)
  7. Conference Paper (2)
  8. Miscellaneous (2)
  9. Meeting Abstract (1)
Groups
  1. Department of Medicine (116)
  2. Survivorship Research (64)
  3. Hematologic Malignancies, Division of (59)
  4. Surgery (59)
  5. Center for Hematologic Malignancies (51)
  6. Solid Tumor Oncology Division (45)

More Groups

People
  1. Miguel-Angel Perales (21)
  2. Sergio Giralt (15)
  3. Sean Devlin (12)
  4. Jonas Nelson (10)
  5. Mario Lacouture (9)
  6. David Jones (8)

More People

Years
  1. 2024 (3)
  2. 2023 (62)
  3. 2022 (106)
  4. 2021 (15)
  5. 2020 (17)
  6. 2019 (11)

More Years

Publications
  1. Transplantation and Cellular Therapy (12)
  2. Journal of Clinical Oncology (10)
  3. Leukemia and Lymphoma (8)
  4. Annals of Surgical Oncology (7)
  5. Journal of the American Academy of Dermatology (7)
  6. Clinical Cancer Research (6)

More Publications

Publishers
  1. Elsevier Inc. (43)
  2. Springer (27)
  3. Lippincott Williams & Wilkins (16)
  4. Elsevier Science, Inc. (15)
  5. Nature Publishing Group (13)
  6. Mosby Elsevier (12)

More Publishers

Results (234)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer: Updated survival results from a phase II trial (DESTINY-Breast01)
    Journal Article

    Saura, C.; Modi, S.; Krop, I.; Park, Y. H.; Kim, S. B.; Tamura, K.; Iwata, H.; Tsurutani, J.; Sohn, J.; Mathias, E.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Iliocaval and iliofemoral venous stenting for obstruction secondary to tumor compression
    Journal Article

    Aly, A. K.; Moussa, A. M.; Chevallier, O.; Kishore, S.; Petre, E.; Friedman, A.; Bryce, Y.; Gonzalez, A.; Camacho, J.; Santos, E.; more...
    CVIR Endovascular (2024)

    Fulltext@MSK | Save
  • How to use anti-PD-1 therapy in gastric cancer: The approach in the United States
    Review

    Ilson, D. H.
    Chinese Clinical Oncology (2024)

    Fulltext@MSK | Save
  • IL12/23 blockade with ustekinumab as a treatment for immune-related cutaneous adverse events
    Journal Article

    Gu, S. L.; Maier, T.; Moy, A. P.; Dusza, S.; Faleck, D. M.; Shah, N. J.; Lacouture, M. E.
    Pharmaceuticals (2023)

    Fulltext@MSK | Save
  • Evaluating immune-related adverse events using PRO-CTCAE in a phase II study of ipilimumab for hormone-sensitive prostate cancer
    Journal Article

    Vargas P. de Almeida, D.; Anderson, J. M.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Abida, W.; Cohn, E. D.; Baser, R. E.; Scher, H. I.; Autio, K. A.
    Journal of Immunotherapy and Precision Oncology (2023)

    Fulltext@MSK | Save
  • Imaging the side effects of CAR T cell therapy: A primer for the practicing radiologist
    Review

    Huang, S.; de Jong, D.; Das, J. P.; Widemon, R. S.; Braumuller, B.; Paily, J.; Deng, A.; Liou, C.; Roa, T.; Huang, A.; more...
    Academic Radiology (2023)

    Fulltext@MSK | Save
  • Moderate adverse events and regional differences in CDK4/6 inhibitor treatment combined with palliative radiotherapy
    Correspondence

    Kubeczko, M.; Jarząb, M.; Gabryś, D.; Krzywon, A.; Cortez, A. J.; Xu, A. J.
    Radiotherapy and Oncology (2023)

    Fulltext@MSK | Save
  • Selecting triple negative breast cancer patients for immunotherapy
    Review

    Downs-Canner, S.; Mittendorf, E. A.
    Surgical Oncology Clinics of North America (2023)

    Fulltext@MSK | Save
  • Prospective feasibility and phase 1/2 trial of preoperative proton beam therapy with concurrent chemotherapy for resectable stage IIIA or superior sulcus non-small cell lung cancer
    Journal Article

    Simone, C. B. 2nd; Yegya-Raman, N.; Manjunath, S.; Verma, V.; Shabason, J. E.; Xu, L.; Cengel, K. A.; Levin, W. P.; Berman, A. T.; Christodouleas, J. P.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • A core outcome set for future research in ectopic pregnancy: An international consensus development study
    Journal Article

    Chong, K. Y.; Solangon, S.; Barnhart, K.; Causa-Andrieu, P.; Capmas, P.; Condous, G.; de Waard, L.; Duffy, J. M. N.; Horne, A. W.; Memtsa, M.; more...
    Fertility and Sterility (2023)

    Fulltext@MSK | Save